{"id":"W2980833094","doi":"10.36469/9820","title":"A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Oncology; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005611343,0.001484295,0.001854338,0.00139281,0.0002108863,0.001765136,0.0009826153,0.001219745,0.00338306],"category_scores_gemma":[0.01301819,0.0007109054,0.00434285,0.001034624,0.0004978034,0.001324185,0.000882144,0.001245184,0.0001533888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007717357,"about_ca_system_score_gemma":0.002595695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01196343,"about_ca_topic_score_gemma":0.008200807,"domain_scores_codex":[0.9964563,0.002858636,0.00009808148,0.0001841237,0.0001993909,0.0002033154],"domain_scores_gemma":[0.9938059,0.005296545,0.0004121037,0.00009179304,0.0001687032,0.0002249589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02530949,0.0007472584,0.0137948,0.003875619,0.008797701,0.00064505,0.00009853522,0.8929099,0.001225399,0.004543962,0.00163385,0.0464185],"study_design_scores_gemma":[0.009064101,0.01272536,0.02632503,0.001957633,0.01387213,0.0009529397,0.0004212689,0.9212955,0.001037358,0.007281849,0.004894421,0.0001724336],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9294314,0.03830695,0.01550926,0.002902959,0.0002098824,0.001428656,0.003903504,0.0001092546,0.008198187],"genre_scores_gemma":[0.9948645,0.002048131,0.001811985,0.0001680117,0.00002287989,0.0001639832,0.0005444912,0.000008371107,0.0003675339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01196343,"threshold_uncertainty_score":0.05599362,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09011777675505077,"score_gpt":0.4229909358078391,"score_spread":0.3328731590527883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}